Mix-and-Match Covid Boosters: Why They Just Might Worknews2021-10-19T18:18:14+00:00October 19th, 2021|The New York Times|
F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shotsnews2021-10-18T23:32:29+00:00October 18th, 2021|The New York Times|
Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?news2021-10-17T21:15:06+00:00October 17th, 2021|The New York Times|
F.D.A. Panel Recommends Moderna Booster for Certain Groupsnews2021-10-15T02:10:00+00:00October 15th, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poornews2021-10-09T15:06:57+00:00October 9th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11news2021-10-08T00:24:12+00:00October 8th, 2021|The New York Times|
Asia-Pacific Countries Rush to Buy Merck Covid Pillnews2021-10-07T12:59:12+00:00October 7th, 2021|The New York Times|
